| Views | |
|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 48 |
| January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | |
|---|---|---|---|---|---|---|---|
| Binimetinib Encorafenib and Cetuximab Triplet Therapy for Patients With BRAF V600E-Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study | 0 | 29 | 0 | 7 | 3 | 5 | 4 |
| Views | |
|---|---|
| artconlli_a2019_tabernero_josep_binimetinib_encorafenib.pdf | 11 |
| Views | |
|---|---|
| United States | 17 |
| China | 7 |
| Canada | 2 |
| Belgium | 1 |
| Spain | 1 |
| Views | |
|---|---|
| Menlo Park | 10 |
| Shanghai | 6 |
| Oakland | 5 |
| Ottawa | 2 |
| Barcelona | 1 |
| Guangzhou | 1 |
| Jackson | 1 |
| San Diego | 1 |